Chugai Pharmaceutical Co., Ltd. (TYO:4519)
7,039.00
-52.00 (-0.73%)
Mar 27, 2025, 3:30 PM JST
Chugai Pharmaceutical Revenue
In the year 2024, Chugai Pharmaceutical had annual revenue of 1.17T JPY with 5.33% growth. Chugai Pharmaceutical had revenue of 300.60B in the quarter ending December 31, 2024, with 9.78% growth.
Revenue
1,170.61B
Revenue Growth
+5.33%
P/S Ratio
9.89
Revenue / Employee
153.95M
Employees
7,604
Market Cap
11.58T
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,170.61B | 59.24B | 5.33% |
Dec 31, 2023 | 1,111.37B | -148.58B | -11.79% |
Dec 31, 2022 | 1,259.95B | 260.19B | 26.02% |
Dec 31, 2021 | 999.76B | 212.81B | 27.04% |
Dec 31, 2020 | 786.95B | 100.76B | 14.68% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionChugai Pharmaceutical News
- 7 weeks ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Chugai Pharmaceutical Co., Ltd. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 weeks ago - Full Year 2024 Chugai Pharmaceutical Co Ltd Earnings Presentation Transcript - GuruFocus
- 2 months ago - Chugai Pharmaceutical GAAP EPS of $253.36, revenue of $1.17B - Seeking Alpha
- 5 months ago - Chugai Pharmaceutical Co., Ltd. 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 5 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market - Benzinga
- 8 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2024 Earnings Call Transcript - Seeking Alpha